SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-18-043575
Filing Date
2018-07-02
Accepted
2018-07-02 17:02:17
Documents
4
Effectiveness Date
2018-07-02

Document Format Files

Seq Description Document Type Size
1 S-8 a18-16065_1s8.htm S-8 112042
2 EX-5.1 a18-16065_1ex5d1.htm EX-5.1 16358
3 EX-23.2 a18-16065_1ex23d2.htm EX-23.2 3897
4 GRAPHIC g160651kei001.gif GRAPHIC 2263
  Complete submission text file 0001104659-18-043575.txt   136560
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-226049 | Film No.: 18933564
SIC: 2834 Pharmaceutical Preparations